UK markets close in 8 hours 6 minutes

Astellas Pharma Inc. (ALPMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.84+0.34 (+3.59%)
At close: 02:14PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1156
Avg. Estimate0.020.190.140.47
Low estimate0.020.190.010.4
High estimate0.020.190.220.56
Year ago EPS-0.180.120.380.14
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3166
Avg. Estimate2.47M2.53M10.21M10.95M
Low estimate2.41M2.53M10.09M10.25M
High estimate2.56M2.53M10.36M11.36M
Year ago sales2.47MN/A10.58M10.21M
Sales growth (year/est)0.10%N/A-3.50%7.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.030.210.20.12
Actual EPS-0.180.12-0.010.07
Difference-0.15-0.09-0.21-0.05
Surprise %-500.00%-42.90%-105.00%-41.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.020.190.140.47
7 days ago0.020.190.20.48
30 days ago0.020.190.330.63
60 days ago0.020.190.340.65
90 days ago0.090.20.380.75
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/AN/AN/A
Up last 30 days1N/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A11
Growth estimatesALPMFIndustrySector(s)S&P 500
Current qtr.111.10%N/AN/AN/A
Next qtr.58.30%N/AN/AN/A
Current year-63.20%N/AN/AN/A
Next year235.70%N/AN/AN/A
Next 5 years (per annum)0.11%N/AN/AN/A
Past 5 years (per annum)-6.56%N/AN/AN/A